home / stock / gsk / gsk articles

GSK Articles, GlaxoSmithKline PLC - From 02/26/24

Stock Information
Company Name: GlaxoSmithKline PLC
Stock Symbol: GSK
Market: NYSE
Website: gsk.com
Menu
GSK GSK Quote GSK Short GSK News GSK Articles GSK Message Board
Get GSK Alerts

News, Short Squeeze, Breakout and More Instantly...
GSK's Gepotidacin Oral Antibiotic Non-Inferior To Commonly Used Muscle-Injected Antibiotic Combo For Sexually Transmitted Infection | Benzinga

Monday, GSK plc (NYSE:GSK) released headline results from the pivotal EAGLE-1 phase 3 trial for gepotidacin, an oral antibiotic...
Why Is Moderna Stock Trading Lower Today? | Benzinga

Moderna Inc (NASDAQ:MRNA) shares are trading lower after a longer-term trial analysis revealed a faster decline in the effectiveness of its ex...

Jim Cramer Expects Drugmaker Stock To Go 'Even Higher,' As For Kroger: 'What The Heck Is Going On?' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer believes in GSK plc (NYSE: GSK). "I think GSK is going even higher than it...

Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations | Benzinga

Under the Inflation Reduction Act, Medicare is poised to send initial offers to manufacturers of the first ten drugs chosen for negotiation, challe...
Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option | Benzinga

Novavax Inc (NASDAQ:NVAX) announced that peer-reviewed results from a Phase 3 efficacy trial of the R21/Matrix-M malaria vaccine wer...

What's Going On With GSK Stock Today? | Benzinga

Thursday, GSK Plc (NYSE:GSK) resolved a U.S. lawsuit concerning its heartburn medicine Zantac shortly before the scheduled tria...

GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine | Benzinga

Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter adjusted operating profit of £1.75 billion, up 10% at the actual exchang...
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser | Benzinga

Disappointing tech tidings appear to be weighing down on the market, with the Nasdaq futures diving in early trading on Wednesday while the Dow fut...

Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60% | Benzinga

Pharmaceutical companies await the U.S. government’s forthcoming proposal, expected this Thursday, outlining substantial discounts for t...

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? | Benzinga

The past week’s earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that woul...
Previous 10 Next 10